Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

Abroad (travel likely)Recruiting

Conditions

Head and Neck Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

IRCCS National Cancer institute, Roma, Rome, Italy
Contact: Study coordinator (Giovanni Blandino, Doctor) · giovanni.blandino@ifo.it · +39 06 52662911

Study leads

Giovanni Blandino, Doctor
Principal Investigator
IRCCS National Cancer Institute

View source on ClinicalTrials.gov